End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,946 ARS | +1.37% | +0.76% | +8.01% |
05:35pm | Ten key beauty players | |
09:57am | Kenvue Prices Secondary Common Stock Offering | MT |
Sales 2024 * | 88.37B 78,252B 7,371B | Sales 2025 * | 90.78B 80,386B 7,572B | Capitalization | 364B 3,22,608B 30,387B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 19,516B 1,838B | Net income 2025 * | 23.09B 20,448B 1,926B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B 6,196B 584B | Net cash position 2025 * | 21.07B 18,662B 1,758B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 1,31,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.37% | ||
1 week | +0.76% | ||
Current month | +3.65% | ||
1 month | +5.92% | ||
3 months | -10.19% | ||
6 months | +27.40% | ||
Current year | +8.01% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 10,946 | +1.37% | 8,291 |
13/24/13 | 10,798 | +0.07% | 6,905 |
10/24/10 | 10,790 | -0.33% | 12,830 |
09/24/09 | 10,826 | +1.18% | 9,409 |
08/24/08 | 10,700 | -1.51% | 8,386 |
End-of-day quote Buenos Aires S.E., May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
+19.56% | 326B | |
+5.19% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.24% | 167B | |
+0.00% | 161B | |
+0.89% | 124B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock